Axsome Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Great. Good day, everyone. Welcome to Bank of America 2021 virtual health care conference.
My name is Ashwani Verma. I cover biotech companies here at Bank of America.
Next company on our virtual stage is Axsome Therapeutics. And joining me today from Axsome is CEO and Chairman, Dr. Herriot Tabuteau.
So Herriot, thanks for joining us today. I just want to go over some of the programs and hear more updates from you, but before we do that, it will be helpful if you can just give a -- like a quick intro to the company for some investors who might not be as familiar.
Sure. Thanks, Ash. And thanks. Thank you for having us at your conference. I think this is the first time that we present at a Bank of America conference.
So Axsome is a CNS-focused company. We're pre commercial. We have filed an NDA for our lead product candidate, which is AXS-05 for the treatment of major
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
